Company / Return on Assets (ROA)
Vanda Pharmaceuticals Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
0.5%
FY2025
5-year range
0.5% / 19.5%
FY2021-FY2025
Trend
-46.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -19.4% in FY2017 to 19.5% in FY2021.
Based on SEC 10-K filings.
0.5% in FY2025 with a 5-year CAGR of -4.2%.
Declined from 5.1% to 0.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -3.2pp
- 5-Year Change
- -4.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 46.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 0.5% | -46.9% |
| FY2024 | 1.0% | -81.2% |
| FY2023 | 5.1% | +38.9% |
| FY2022 | 3.7% | -81.1% |
| FY2021 | 19.5% | +311.4% |
| FY2020 | 4.7% | +246.9% |
| FY2019 | -3.2% | +40.6% |
| FY2018 | -5.4% | +72.1% |
| FY2017 | -19.4% | -302.2% |
| FY2016 | 9.6% | +197.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026